Table 1.
Patient characteristics of the included five cancer entities.
| All Analyzed Patients (n = 12,577) |
HCC (n = 7146) |
iCC (n = 1858) |
eCC (n = 1649) |
GBC (n = 1365) |
AC (n = 559) |
||
|---|---|---|---|---|---|---|---|
| Variable | n (%) | n (%) | n (%) | n (%) | n (%) | ||
| Age | Mean ± SD | 71 ± 11.7 | 70 ± 11.5 | 71 ± 12.0 | 73 ± 11.4 | 71 ± 11.2 | 71 ± 12.2 |
| Sex | Male | 7959 (63) | 5342 (75) | 997 (54) | 884 (54) | 437 (32) | 299 (54) |
| (n (%)) | Female | 4618 (37) | 1804 (25) | 861 (46) | 765 (46) | 928 (68) | 260 (46) |
| Metastases (n (%)) | Lymph node 1 | 1190 (10) | 310 (4) | 167(9) | 289 (18) | 255 (19) | 169 (30) |
| Distant 2 | 1489 (12) | 574 (8) | 412 (22) | 214 (13) | 343 (25) | 43 (8) |
Abbreviations: HCC, hepatocellular carcinoma; iCC, intrahepatic cholangiocarcinoma; eCC, extrahepatic cholangiocellular carcinoma; GBC, gallbladder carcinoma; AC, ampullary carcinoma. STD, standard deviation. 1 Not evaluable, n = 2629 (21%). 2 Not evaluable, n = 1755 (14%).